Veritas Announces the Sale of 3 Carbon Extractions Inc.
July 10, 2019 17:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, July 10, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has completed the sale of...
Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain
May 15, 2019 08:00 ET
|
Veritas Pharma Inc.
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is...
Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility
February 12, 2019 09:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Veritas Pharma Signs MOU with Santa Marta Gold Holdings for a Medical Cannabis Research Collaboration
January 15, 2019 09:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
April 16, 2018 07:30 ET
|
Veritas Pharma Inc.
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Veritas...
Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel
March 15, 2018 03:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that Justin Kausel has...
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
January 04, 2018 17:24 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board
November 29, 2017 16:30 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob”...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
November 28, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
November 22, 2017 16:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that the scientists of its research...